• Fri news: Eisai/Biogen Alzheimers med. BMS earnings beat. Big Pharma unfazed by IRA. Indivior opioid settlement. Abbott CGM recall. —http://bit.ly/w28kSd — See more on our front page

Biosurgery....What's the point????

Quote

anonymous

Guest
This is getting utterly depressing. We have lost an incredible amount of business in the east, mostly Philly and NYC. I was killing Baxter prior to these issues, but now it looks like my territory is toast. I am looking at almost 1.5 million in losses. Think it's time to go!!
 
















anonymous said:
This is getting utterly depressing. We have lost an incredible amount of business in the east, mostly Philly and NYC. I was killing Baxter prior to these issues, but now it looks like my territory is toast. I am looking at almost 1.5 million in losses. Think it's time to go!!
Click to expand...

Sorry Brian Johns.
 




















































Takeda deal fell through so no fibrin sealant patch… they removed Ominix years ago. Evarrest is to expensive to make so only 50+ hospitals get it. If that

FULL PORTFOLIO? You tell me-

It’s Ethicon pulling their “marketing shit”

Slime of Medical Device, please watch “ Breaking Edge” on Netflix. CORRUPTION!
 













Top Bottom
Back
Quote